Nanotechnology has witnessed remarkable advancements in recent years, capturing considerable attention in diverse biomedical applications. Using the green precipitation method, this study aims to synthesize and characterize chitosan/polyvinyl alcohol-copper oxide nanocomposites (CS/PVA/CuONCs) using Anacardium occidentale plant fruit extract. The CS/PVA/CuONCs were further evaluated in antioxidant, antibacterial and biological activities. In our study results, UV–Vis spectrum analysis of CS/PVA/CuONCs revealed a peak at 430 nm. FTIR analyses confirmed the presence of different functional groups, while the XRD study confirmed the crystalline structure of the synthesized nanocomposites. FESEM-EDAX analysis demonstrated that the CS/PVA/CuONCs exhibited a spherical and rod-like shape, with an average particle size of 48.6 to 96.2 nm. Notably, CS/PVA/CuONCs exhibited higher antioxidant activity, as evidenced by their ABTS activity (83.79 ± 1.57%) and SOD activity (86.17 ± 1.28%). In antibacterial assays, CS/PVA/CuONCs demonstrated inhibition in Escherichia coli at 20.52 ± 0.85 mm and Bacillus subtilis at 19.64 ± 0.87 mm, displaying a zone of inhibition. The CS/PVA/CuONCs exhibited excellent anti-inflammatory potency against COX-1 (67.10 ± 0.58%) and COX-2 (76.39 ± 0.65%). The antidiabetic assay revealed excellent α-amylase inhibition (80.25 ± 1.29%) and α-glucosidase inhibition (84.74 ± 1.42%) activities. Anti-cholinergic activity of AChE was 65.35 ± 0.98% and BuChE was 82.46 ± 1.15% are observed. CS/PVA/CuONCs was shown to have strong cytotoxicity against MCF-7 cell lines. It also had the highest cell viability inhibition, at 13.66 ± 0.58%. The hemolysis activity was found to be 5.38 ± 0.34%. Overall, the study demonstrated that CS/PVA/CuONCs possess remarkably excellent biological activities.
Nanotechnology has experienced significant advancements, attracting considerable attention in various biomedical applications. This innovative study synthesizes and characterizes Ge/PLA/AuNCs (gelatin/PLA/gold nanocomposites) using Syzygium cumini extract to evaluate their various biomedical applications. The UV–Visible spectroscopy results in an absorption peak at 534 nm were primarily confirmed by Ge/PLA/AuNCs synthesis. The FTIR spectrum showed various functional groups and the XRD patterns confirmed the crystalline shape and structure of nanocomposites. The FESEM and HRTEM results showed a oval shape of Ge/PLA/AuNCs with an average particle size of 21 nm. The Ge/PLA/AuNC’s remarkable antioxidant activity, as evidenced by DPPH (70.84 ± 1.64%), ABTS activity (86.17 ± 1.96%), and reducing power activity (78.42 ± 1.48%) at a concentration of 100 μg/mL was observed. The zone of inhibition against Staphylococcus aureus (19.45 ± 0.89 mm) and Echericia coli (20.83 ± 0.97 mm) revealed the excellent antibacterial activity of Ge/PLA/AuNCs. The anti-diabetic activity of Ge/PLA/AuNCs was supported by inhibition of α-amylase (82.56 ± 1.49%) and α-glucosidase (80.27 ± 1.57%). The anti-Alzheimer activity was confirmed by inhibition of the AChE (76.37 ± 1.18%) and BChE (85.94 ± 1.38%) enzymes. In vivo studies of zebrafish embryos showed that Ge/PLA/AuNCs have excellent biocompatibility and nontoxicity. The SH-SY5Y cell line study demonstrated improved cell viability (95.27 ± 1.62%) and enhanced neuronal cell growth following Ge/PLA/AuNCs treatment. In conclusion, the present study highlights the cost-effective and non-toxic properties of Ge/PLA/AuNCs. Furthermore, it presents an attractive and promising approach for various future biomedical applications.
16 September 2024 in Bioprocess and Biosystems Engineering